Brand Institute Partners on Brand Name Development for FDA Approved Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
MIAMI, July 11, 2022 /PRNewswire/ — Brand Institute is proud to announce its work with Osmotica Pharmaceuticals in developing the…